Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Thromboxane A2 receptor TPβ is a G protein-coupled receptor involved in platelet aggregation and vasoconstriction. It is one of two isoforms, TPα and TPβ, with TPβ having a longer C-terminal tail that influences receptor internalization and desensitization. TPβ is expressed in endothelial cells and plays a role in cardiovascular diseases by mediating thromboxane A2 (TXA2) effects, which are crucial in hemostasis and pathogenesis of cardiovascular disorders. Despite its potential as a therapeutic target, developing effective drugs for TPβ remains challenging due to efficacy and toxicity issues.
Activation of Gq, Gi, and Gs proteins, leading to vasoconstriction and platelet aggregation; potential drugs may inhibit these pathways to prevent thrombotic events.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Thromboxane A2 receptor TPβ (TPβ).